Emphasis on Age Group (Senior Citizens, Adults, and Minors); Distribution channel (Direct Sales, Brokers/Agents, Banks, and Others); and Region/Country
The Private Health Insurance Market was valued at approximately ~USD 1 billion in 2023 and is expected to grow at a strong CAGR of around ~6% during the forecast period (2024-2032) owing to growing use of telehealth services covered by insurance plans.
The Private Health Insurance Market is expected to grow as consumers seek more convenient, reusable, and innovative solutions. The health and wellness trends significantly influence the growth of the private health insurance market, particularly through the increasing demand for non-dairy alternatives and heightened nutritional awareness among consumers. These trends reshape consumer preferences and drive manufacturers to innovate and adapt their product offerings. Company collaborations and innovative product launches also drive the industry’s growth.
For instance, in 2023 AXA completed the acquisition of Groupe Assurances du Crédit Mutuel España (GACM España) for a total cash consideration of €310 million (337.37 USD MN). This deal reflects price-to-own funds multiple of 1x and an estimated price-to-earnings multiple of approximately 9x, considering expected capital and cost synergies.
This section discusses the key market trends that are influencing the various segments of the private health insurance market, as identified by our team of research experts.
Brokers/Agents Segment Transforming Industry
Brokers and agents are key to the growth of the private health insurance market since they act as intermediaries between insurance providers and purchasers. Brokers provide unique recommendations and actively assist in collecting information about the targets and searching for the most suitable health insurance plans. Doctors and physicians understand different insurance products and could give detailed information regarding the coverage benefits and limitations of the insurance policy as well as the insurance premium charges. The key advantages of unifying them include customer trust and loyalty based on long-standing cooperation. Furthermore, brokers and agents have direct contacts with insurance companies, and they possess full features, offers, and individual sales plans that are not available to the public and thus are part of the health insurance distribution systems. Firms across the market benefit greatly from their specialized skills and the services they provide concerning health coverage for consumers.
Rapid urbanization and increasing disposable incomes in countries like China, India, and Southeast Asian nations are expanding the middle class, which in turn is driving higher demand for private health insurance as people seek better and more personalized healthcare services. The region’s growing awareness of health issues and the rising burden of non-communicable diseases are also contributing to the market’s expansion. Additionally, the proliferation of digital health technologies and telemedicine in the APAC region is enhancing access to healthcare services, making private health insurance more appealing by offering added convenience and improved service delivery.
The Private Health Insurance Market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new type launches, geographical expansions, and mergers and acquisitions. Some of the major players operating in the market are Health Care Service Corporation; AXA; Cigna Healthcare; Humana; Allianz; Bupa; Centene Corporation; UNITEDHEALTH GROUP; Anthem Insurance Companies, Inc.; Ping An Insurance (Group) Company of China, Ltd.
The global private health insurance market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Executive Summary
4. Market Dynamics
5. Global Private Health Insurance Market Revenue (USD Bn), 2022-2032f
6. Market Segment By Age Group
7. Market Insights By Distribution Channel
8. Market Insights By Region
9. Value Chain Analysis
10. Competitive Landscape
11. Company Profiled
12. Acronyms & Assumption
13. Annexure
Analyzing the historical market, estimating the current market, and forecasting the future market of the global private health insurance market were the three major steps undertaken to create and analyze the adoption of Private Health Insurance in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global Private Health Insurance market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Step 1: In-Depth Study of Secondary Sources:
A detailed secondary study was conducted to obtain the historical market size of the Private Health Insurance market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Private Health Insurance market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as age group and distribution channel, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Private Health Insurance market. Further, we conducted factor analysis using dependent and independent variables such as age group, distribution channel, and regions of the Private Health Insurance market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and type launches in the Private Health Insurance market sector across the globe.
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Private Health Insurance market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2032 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Private Health Insurance market. Data was split into several segments and sub-segments after studying various parameters and trends in the age group and distribution channel, and regions in the global Private Health Insurance market.
The current & future market trends of the global Private Health Insurance market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the private health insurance market's current market size and growth potential?
Q2: What are the driving factors for the growth of the private health insurance market?
Q3: Which segment has the largest share of the private health insurance market by age group category?
Q4: What are the emerging technologies and trends in the private health insurance market?
Q5: Which region will dominate the private health insurance market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
